The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum

Toptas T., Pestereli E., ŞİMŞEK T., Bozkurt S., ERDOĞAN G., Karaveli S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.14, sa.3, ss.587-592, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4103/0973-1482.172130
  • Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.587-592
  • Anahtar Kelimeler: High-grade serous carcinoma, serous tubal intraepithelial carcinoma, survival, PROPHYLACTIC OOPHORECTOMY SPECIMENS, CANCER, ADENOCARCINOMA, FIMBRIA, TUMORS, WOMEN, P53
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Aims: To investigate whether the presence of serous tubal intraepithelial carcinoma (STIC) is associated with clinical outcomes in a nonselected (unknown BRCA status) cohort of patients with a high-grade serous carcinoma (HGSC) of the ovary, fallopian tube, and peritoneum.